ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

AGS-003 Increased Survival In Combination with Sunitinib

February 24, 2012

Turmoil in Texas: AVEO, DePinho Joined at the Hip (Pocket)

May 8, 2013

Study: Vismodegib Effective Where Surgery is Inappropriate

June 24, 2011

Ovarian Cancer Screening Finds Cancers, But Also Many False Positives, Study Says

November 25, 2005

DRCCA Concept Approvals; RFP For Evolution Of Three Programs; RFA For Cancer Care Of Elderly, New Physician Investigator Awards

October 29, 1982

Trials Suspended At Oklahoma Over Study Of Cancer Vaccine.

July 14, 2000